CLINICAL_TRIALS
trial_result
· 2014-10-24
Clinical Trial Update: Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old [Phase 3]
Summary
Phase 3 clinical trial updating atropine treatment for amblyopia in children aged 3 to under 8; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED | Results posted: 2014-10-24